George A. Fisher Jr.

Back to Profile

Publication Details

  • Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies.

    Cho CD, Fisher GA, Halsey J, Sikic BI. Invest New Drugs. 2006; 24 (2): 117-23

    Aphase 1 study of gefitinib in combination with oxaliplatin, 5-fluorouracil and leucovorin (IFOX)was conducted to evaluate the safety and feasibility of this regimen.

    PubMedID: 16683204

Stanford Medicine Resources:

Footer Links: